Skip to main content
Log in

Long-term therapy with recombinant human growth hormone (Saizen®) in children with idiopathic and organic growth hormone deficiency

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

In an open-label study, 69 children with organic or idiopathic growth hormone deficiency (GHD) were treated with recombinant human growth hormone (Saizen®) for an average of 64.4 mo, with treatment periods as long as 140.9 mo. Auxologic measurements, including height velocity, height standard deviation score, and bone age, were made on a regular basis. The data suggest that long-term treatment with Saizen in children with GHD results in a positive catch-up growth response and proportionate changes in bone age vs height age during treatment. In addition, long-term Saizen therapy was well tolerated, with the majority of adverse events related to common childhood disorders or existing baseline medical conditions and not to study treatment. There were no significant changes in laboratory safety data or vital signs, and no positive antibody tests for Saizen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Milner, R. D. J., Russell-Fraser, T., Brook, C. G. D., Cotes, P. M., Farquhar, J. W., Parkin, J. M., Preece, M. A., Snodgrass, J. A. I., Mason, A. S., Tanner, J. M., and Vince, F. P. (1979). Clin. Endocrinol. 11, 15–38.

    CAS  Google Scholar 

  2. Frasier, S. D., Rudlin, C. R., Zeisel, H. J., Lui, H. H., Long, P. C., Senior, B., Finegold, D. N., Bercu, B. B., Marks, J. F., and Redmond, J. P. (1992). Am. J. Dis. Child. 146, 582–587.

    PubMed  CAS  Google Scholar 

  3. Stubbe, P., Frasier, S. D., Stahnke, N., Cacciari, E., Job, J. C., Preece, M., Frisch, H., Zachmann, M., and Zeisel, H. J. (1992). Horm. Res. 37(Suppl. 2), 28–36.

    Article  PubMed  Google Scholar 

  4. Coste, J., Letrait, M., Carel, J. C., Tresca, J. P., Chatelain, P., Rochiccioli, P., Chaussain, J. L., and Job, J. C. (1997). BMJ 315, 708–713.

    PubMed  CAS  Google Scholar 

  5. Frasier, S. D. (1983). Endocr. Rev. 4, 155–170.

    PubMed  CAS  Google Scholar 

  6. Sato, T., Suzuki, Y., Taketani, T., Ishiguro, K., Masuyama, T., Takata, I., Sano, M., Kawashima, H., Koizumi, S., and Nakajima, H. (1977). J. Clin. Endocrinol. Metab. 45, 324–329.

    PubMed  CAS  Google Scholar 

  7. Lippe, B. M., Van Herle, A. J., LaFranchi, S., Uller, R. P., Lavin, N., and Kaplan, S. A. (1975). J. Clin. Endocrinol. Metab. 40, 612–618.

    PubMed  CAS  Google Scholar 

  8. LaFranchi, S., Hanna, C. E., and Illingworth, D. R. (1985). J. Pediatr. 106, 588–593.

    Article  PubMed  CAS  Google Scholar 

  9. Pirazzoli, P., Cacciari, E., Mandini, M., Sganga, T., Capelli, M., Cicognani, A., and Gualandi, S. (1992). J. Pediatr. 121, 210–213.

    Article  PubMed  CAS  Google Scholar 

  10. Municchi, G., Malozowski, S., Nisula, B. C., Thompson, R. G., and Draper, M. W. (1990). Acta Paediatr. Scand. Suppl. 367, 44–48.

    Google Scholar 

  11. Holcombe, J. H., Conforti, P. M., Wong, A. C., Thompson, R. G., and Draper, M. W. (1990). Acta Paediatr. Scand. Suppl. 367, 44–48.

    PubMed  CAS  Google Scholar 

  12. Tanner, J. M., Whitehouse, R. H., and Takaishi, M. (1966). Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children. Arch. Dis. Child. 41, 454–471.

    PubMed  CAS  Google Scholar 

  13. Tanner, J. M. and Davies, P. S. (1985). Clinical longitudinal standards for height and height velocity for North American children. J. Pediatr. 107, 317–329.

    Article  PubMed  CAS  Google Scholar 

  14. Hamill, P. V. V., Drizd, T. A., Johnson, C. L., Reed, R. B., Roche, A. F., and Moore, W. M. (1979). Am. J. Clin. Nutr. 32, 607–629.

    PubMed  CAS  Google Scholar 

  15. Greulich, W. W. and Pyle, S. I. (1959). Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press: Stanford, CA.

    Google Scholar 

  16. Tanner, J. M., Whitehouse, R. H., Marshall, W. A., Healy, M. J. R., and Goldstein, H. (1975). Assessment of skeletal maturity and prediction of adult height (TW2 method). Academic: Orlando, FL.

    Google Scholar 

  17. Frasier, S. D. (1967). J. Pediatr. 71, 625–638.

    Article  PubMed  CAS  Google Scholar 

  18. Root, A. W. and Russ, R. D. (1972). J. Pediatr. 81, 808–813.

    Article  PubMed  CAS  Google Scholar 

  19. Parker, M. L., Hammond, J. M., and Daughaday, W. H. (1967). J. Clin. Endocrinol. Metab. 27, 1129–1136.

    Article  PubMed  CAS  Google Scholar 

  20. Gil-Ad, I., Topper, E., and Laron, Z. (1979). Lancet 2, 278.279.

    Article  PubMed  CAS  Google Scholar 

  21. Mitchell, M. L., Byrne, M. J., Sanchez, Y., and Sawin, C. T. (1970). N. Engl. J. Med. 282, 539–541.

    Article  PubMed  CAS  Google Scholar 

  22. Prader, A., Largu, R. H., Molinari, L., and Issler, C. (1989). Acta Paediatr. 52, 1–125.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barry B. Bercu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bercu, B.B., Murray, F.T., Frasier, S.D. et al. Long-term therapy with recombinant human growth hormone (Saizen®) in children with idiopathic and organic growth hormone deficiency. Endocr 15, 43–49 (2001). https://doi.org/10.1385/ENDO:15:1:043

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:15:1:043

Key Words

Navigation